Resources involved in managing retinal detachment complicated by proliferative vitreoretinopathy

Retina

Volumn 24, Issue 6, 2004, Pages 883-887

  Patel, Nandesh N ^a   Bunce, Catey ^a   Asaria, Riaz H ^a   Charteris, David G ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Healthcare resources; Proliferative vitreoretinopathy; Retinal detachment

Indexed keywords

ARTICLE; CATARACT EXTRACTION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; RETINA DETACHMENT; VISUAL ACUITY; VITREORETINOPATHY;

ADOLESCENT; ADULT; COST OF ILLNESS; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RETINAL DETACHMENT; VISUAL ACUITY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 10644269873     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200412000-00007     Document Type: Article

References (14)

1. Rachal WF, Burton TC. Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol 1979;97:480-483.
2. Gilbert C, McLeod D. D-ACE surgical sequence for selected bullous retinal detachments. Br J Ophthalmol 1985;69:733-736.
3. Sullivan PM, Luff AJ, Aylward GW. Results of primary reattachment surgery: a prospective audit. Eye 1997;11:869-871.
4. Wong D, McGalliard J. Are we getting better at treating retinal detachment? Technology, referral pattern or primary care? Eye 1997;11:763-764.
5. Newman DK, Burton RL. Primary vitrectomy for pseudophakic and aphakic retinal detachments. Eye 1999;13:635-639.
6. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management and adjunctive treatment. Br J Ophthalmol 1995;79:953-960.
7. Andenmatten R, Gonvers M. Sophisticated vitreoretinal surgery in patients with a healthy fellow eye. An 11 year retrospective study. Graefes Arch Clin Exp Ophthalmol 1993;231:495-499.
8. McCormack P, Simcock P, Charteris DG, Lavin MJ. Is surgery for proliferative vitreoretinopathy justifiable? Eye 1994;8:75-76.
9. Lichter PR. Anatomic success and vitreoretinal surgery. Ophthalmology 1988;95:857-858.
10. Asaria RH, Kon CH, Bunce C, et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology 2001;108:1179-1183.
11. Silicone Study Group. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Arch Ophthalmol 1992;110:780-792.
12. Hanneken AM, Michels RG. Vitrectomy and scleral buckling methods for proliferative vitreoretinopathy. Ophthalmology 1988;95:865-869.
13. Lewis H, Aaberg TM, Abrams GW. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol 1991;111:8-14.
14. Lewis H, Aaberg TM. Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. Am J Ophthalmol 1991;111:15-19.